朗姿股份(002612.SZ):第三期員工持股計劃完成股票購買
格隆匯 3 月 23日丨朗姿股份(002612.SZ)公佈,截至公吿披露日,公司第三期員工持股計劃通過開立的專用證券户(賬户名稱:朗姿股份有限公司-第三期員工持股計劃,證券賬號:089926****)採取大宗交易方式受讓公司2014年第一期員工持股計劃和2016年第二期員工持股計劃出售的朗姿股份股票,累計買入股票942萬股,佔公司股本總額的2.13%,成交金額為2.81億元,成交均價為29.84元/股,已經完成本期員工持股計劃的股票購買。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.